Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Quarterly results round-up: Illumina better than expected, Thermo Fisher raises guidance

This article was originally published in Clinica

Executive Summary

Gene sequencing firm Illumina reported better-than-expected results for its first fiscal quarter. Revenues of $272.7m were above its previous guidance of $250-260m, as per the preliminary results the company posted earlier this month when it forecast revenues of around $270m (, 3 April 2012). However, sales were down 3% compared with last year's Q1.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts